fewer new cases of type 2 diabetes with a lifestyle programme than placebo over 2.8 years (metformin: 31%) — 11 vs 4.8 cases per 100 person-years. Diabetes Prevention Program, 3,234 adults.1
After the GLP-1 benefit
The year after the last dose
Most people who stop a GLP-1 without a plan regain much of the weight within a year, and the value of the benefit falls with it. In a 2026 pilot of adults who had just stopped a GLP-1, structured support cut early regain to about 3.6% of body weight, against about 11% with usual care.
Evidence
What the trials show
On treatmentOff treatment
The numbers
| Tirzepatide continued | -5.5% |
| Switched to placebo | +14.0% |
| Semaglutide, 68 weeks | -17.3% |
| The year after stopping | +11.6% |
severe complications after colorectal cancer surgery, usual care vs four weeks of multimodal prehabilitation (odds ratio 0.47). Medical complications 27.3% → 15.4%. PREHAB trial, 251 patients.2
medical and absenteeism costs saved per dollar spent, in the Harvard meta-analysis of workplace wellness programmes.3
spending measures, and 0 of 10 clinical markers, moved in 18 months in the largest randomized trial of a conventional wellness programme; only self-reported behaviours changed. AthleticsMD’s programmes are clinical, with outcomes measured and reported.4
Cost per person
Published costs of obesity, per person per year
Published cost per person per yearNo Regain, per enrolled member per year
The numbers
| Added medical cost, adult with obesity | $2,505 |
| Added medical cost, private insurance | $2,058 |
| Grade III obesity, men, with lost work | $6,087 |
| Grade III obesity, women, with lost work | $6,694 |
| No Regain Essentials, a year | $300 |
| No Regain Clinical, a year | $540 |
Across full-time employees, obesity cost $73.1 billion a year in medical spending and lost work; people with a BMI over 35 were 37% of those with obesity and 61% of the excess cost8. The national medical bill for obesity was $260.6 billion in 20167.
GLP-1 coverage
Employer coverage of GLP-1 drugs in 2025
The numbers
| 200–999 workers | 16% |
| 1,000–4,999 workers | 30% |
| 5,000 or more workers | 43% |
No Regain is priced for the members who stop the medicine; members who never enroll cost nothing.
Services
Services available under contract
The year after GLP-1
A daily program for employees coming off the medicine: three personal actions a day, food-noise SOS, a 40-lesson course, 27 cuisines, in English and Spanish; a clinician in the loop on the Clinical plan. Priced per enrolled member; employees who never enroll cost nothing.
Medical weight management under a physician
Tirzepatide or semaglutide with weekly physician check-ins, weekly metabolic labs and a nutrition and strength plan that protects muscle — for members who need the medicine, with No Regain for the year after.
Members facing surgery
Strength, nutrition, heart and lung conditioning before an operation, with physician oversight, in clinic and by video, and a readiness letter for the surgeon.
Energy, sleep, strength
Women’s and men’s hormone care and preventative, functional care, built on labs, at Columbia and Laurel with follow-ups by video.
Seen this week, or today
Same-day sick visits, IV hydration and recovery, and ketamine-assisted therapy for chronic pain. Call before 2 PM for a same-day visit.
Maryland, Washington DC and Virginia
Follow-ups by video from a link in any browser — no download, no log-in — on SmartMeet, the platform AthleticsMD built and runs.
No Regain plans
No Regain plans, per enrolled member
Essentials
$25 per enrolled member / month
The daily program.
- Daily check-in and three personal actions
- Food-noise SOS, introspection and the 40-lesson course
- 27 cuisines and the movement library, English and Spanish
- Enrollment link, benefits portal and group outcomes
- One monthly invoice
Clinical
$45 per enrolled member / month
The program, with a clinician in the loop.
- Everything in Essentials
- Struggling score with a consented report to the employee’s own doctor
- Escalation to an AthleticsMD physician visit when the score holds high
- Monthly group coaching
Enterprise
From $35 per member / month · 500+ enrolled
Clinical, at scale, on your terms.
- Everything in Clinical
- Eligibility file: only listed employees can enroll; leavers close at month end
- Single sign-on, scoped in your agreement
- A named success manager and quarterly outcomes reviews
Invoiced monthly in arrears for each member enrolled on any day of the month. Employees who never enroll cost nothing. The same plans, at the same prices, are on noregainapp.com/employers.
Reporting and privacy
What the employer receives
You see
- How many people enrolled, and how many are checking in.
- Group outcomes, made monthly and rounded: weight held at 90 and 180 days, food noise, staying with it. Only from members who agreed to the evaluation, and only once there are at least ten of them.
- Your invoices, by count.
You never see
- Who enrolled. No name, address, weight, check-in, mood score or clinician report ever reaches an employer.
- Your eligibility list is kept as one-way hashes, not addresses.
- Clinician reports go only to the employee’s own doctor, only with the employee’s consent.
Contracting
How to contract
- Request a proposal. Tell us roughly how many people are on your GLP-1 benefit, and which of our care your members need most.
- Agree the plan. We send a written proposal and agreement. Enterprise terms are set together.
- Launch. Your employees get an enrollment link and code; your team gets the benefits portal.
Questions
Frequently asked questions
What can an employer or health plan contract with AthleticsMD?
No Regain for the year after GLP-1, priced per enrolled member; physician-led medical weight management (ShredRx); surgical prehabilitation for members facing an operation; hormone, longevity and same-day care at our clinics in Columbia and Laurel, Maryland; and telehealth follow-ups for members in Maryland, Washington DC and Virginia.
What does No Regain cost an employer?
Essentials: $25 per enrolled member / month; Clinical: $45 per enrolled member / month; Enterprise: From $35 per member / month · 500+ enrolled. Invoiced monthly in arrears for each member enrolled on any day of the month. Employees who never enroll cost nothing.
What do we see about our people?
How many people enrolled, and how many are checking in. Group outcomes, made monthly and rounded: weight held at 90 and 180 days, food noise, staying with it. Only from members who agreed to the evaluation, and only once there are at least ten of them. Your invoices, by count. You never see who enrolled: No name, address, weight, check-in, mood score or clinician report ever reaches an employer.
Is there evidence?
In a 2026 pilot of adults who had just stopped a GLP-1, structured support cut early regain to about 3.6% of body weight, against about 11% with usual care. With consent, No Regain measures weight at 30, 90 and 180 days, food noise, well-being (WHO-5) and mood (PHQ-4), and reports them de-identified.
How do we start?
Request a proposal at https://noregainapp.com/employers or write to info@athleticsmd.org with the subject “Workforce health proposal — AthleticsMD”. We send a written proposal and agreement; Enterprise terms are set together.
Sources
Sources
- PubMed Knowler WC et al., Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.
- PubMed Molenaar CJL et al.. Multimodal prehabilitation and postoperative complications after colorectal cancer surgery: the PREHAB randomized clinical trial. JAMA Surg 2023;158(6):572–581.
- PubMed Baicker K, Cutler D, Song Z. Workplace wellness programs can generate savings (meta-analysis). Health Aff 2010;29(2):304–311.
- PubMed Song Z, Baicker K. Effect of a workplace wellness program on employee health and economic outcomes: a randomized clinical trial (160 worksites, 32,974 employees). JAMA 2019;321(15):1491–1501.
- PubMed Aronne LJ et al.. Continued treatment with tirzepatide for maintenance of weight reduction: the SURMOUNT-4 randomized clinical trial. JAMA 2024;331(1):38–48.
- PubMed Wilding JPH et al.. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab 2022;24(8):1553–1564.
- PubMed Cawley J et al.. Direct medical costs of obesity in the United States and the most populous states. J Manag Care Spec Pharm 2021;27(3):354–366 (funded by Novo Nordisk).
- PubMed Finkelstein EA et al.. The costs of obesity in the workplace. J Occup Environ Med 2010;52(10):971–976.
- Survey KFF. 2025 Employer Health Benefits Survey: coverage of GLP-1 drugs for weight loss, firms with 200 or more workers. October 2025.
Journal articles are cited from PubMed with their DOIs. Market sizes are research firms’ projections, each with its own scope and base year, quoted as published and not combined. Company figures are from the companies’ own filings and publications.
Ask Uri’El · our virtual assistant
Questions about any of our services? Ask Uri’El.
Uri’El knows every service, price and program here, explains what may fit you, and books you in, in plain words. When something needs a physician, Uri’El says so and brings in the team.
Uri’El is an automated assistant, not a clinician, and not for emergencies: call 911. Please don’t share medical details in the chat; the team takes those at your visit.